Sandra Herrmann MD, FASN

Nephrologist @MayoClinicNeph. Professor of Medicine @mayoclinic. Tweets are my own. #Onconephrology & Hypertension

[Sandra Herrmann MD, FASN @HerrmannMd]

TNF-α Blockade Mitigates Immune Checkpoint-Related Nephritis in a Humanized Mouse Model
⁦@JCI_insight⁩
@VictorCuenca3 @MayoClinicNeph
@onconephsociety
#onconephrology
First Immunocompetent chimeric 🐁 Model of ICI-AIN ! https://t.co/XNMpkDadxc

[American Society of Onconephrology @onconephsociety]

Update on Paraproteinemia and Kidney Pathologies: Monoclonal vs. Monotypic

This session by Lihong Bu will look at monoclonal vs. monotypic patterns and the renal pathologies we need to recognise.
@onconeph @SheronLatcha @rc_oncneph @ShrutiGkidney

[American Society of Onconephrology @onconephsociety]

Next off, we discuss Novel Radioligand Therapies and Nephrotoxicity

This session by @rc_oncneph will focus on these newer therapies and an important question for nephrologists: what do we need to know about their renal effects?

@onconeph @SheronLatcha @ShrutiGkidney

[Maria Jose Soler @PepaSolerR]

Superimposed FSGS worsens Kidney Prognosis in DN ‼️ Risk factor for progression, the clue by 🫘 biopsy. @SethiRenalPath @mvargas07 @mimamed @Daniela95926028 @martacasalmoura @boulboulasana

https://t.co/UE28yQjhw1

[Leticia Rolon @LeticiaRolonMD]

Day 2 of @MayoClinicNeph 2026 Selected Topics in Glomerular Diseases & Kidney Pathology starting off with our fearless leader, Dr. Vesna Garovic, sharing opening remarks highlighting the impact of Mayo Clinic in the field of Nephrology, as well as upcoming courses. Stay tuned!

[Leticia Rolon @LeticiaRolonMD]

Starting our afternoon session with a very important topic: Pregnancy Discussion and Planning in Patients with Glomerular Diseases given by our @MayoClinicNeph expert in women’s health, Dr. Andrea Kattah.

[Fernando Fervenza @fervenzaf]

Dr. Glassock presenting on treatment of primary podocytopaties at the Mayo GNs Course.

[American Society of Onconephrology @onconephsociety]

Here’s the ASN Onconephrology Program at #KidneyWeek 2026 in Denver.

A full day covering new therapies, kidney complications of cancer treatment, transplant, pathology, immunotherapy, & case-based discussions.

Hope to see many of you there!
@onconeph @rc_oncneph @SheronLatcha

[Sandra Herrmann MD, FASN @HerrmannMd]

@onconephsociety @onconeph @rc_oncneph @SheronLatcha @anuja_java @ShrutiGkidney @hhashmi87 @ZiolkowskiSusan @nymurakami @virginieroyal @PaulHannaMD @gabriellecote @itunuowoyemi @kdjhaveri https://t.co/wKH69JiY3p

[Jose Arriola-Montenegro @josearriolam]

Thrilled to share our review on contrast-associated acute kidney injury, now published in Mayo Clinic Proceedings @MayoProceedings ! 🎉

This was a wonderful collaboration across cardiology, radiology, and nephrology. I’m so grateful to the entire team and our mentors for their guidance and support! 🔥🔥🙌🏼🙌🏼@mandeep_mayo @wisit661 @FredRiveraMD @Arjun_Mohan1 @MayoClinicNeph @MayoClinicCV @MayoRadiology @MayoClinic

https://t.co/aaZixn5Zl5

[Leticia Rolon @LeticiaRolonMD]

What a treat to have Dr. Dario Roccatello from the University of Turin here @MayoClinicNeph to give an update on the Diagnosis & Management of Cryoglobulinemic Vasculitis to a captive audience.

[Wisit Cheungpasitporn MD FACP | FASN | FAST @wisit661]

😊🙏🏻Looking forward to joining the Society of Transplantation Singapore (SOT) Annual Scientific Meeting 2026 this Saturday! 🇸🇬 
I am incredibly honored to deliver the keynote plenary:
“AI in Transplantation — From Promise to Practice” 
During our session, we will explore where AI is already beginning to influence transplantation, including:
🔹 Risk Stratification & Outcomes: Utilizing predictive modeling to improve patient care trajectories
🔹 Advanced Diagnostics: The integration of digital pathology, molecular diagnostics, and biomarkers
🔹 Decision Support: Leveraging multimodal data integration to empower clinicians and support precision medicine 
Crucially, we will also discuss what is still needed to move from promising algorithms toward reliable, clinically useful systems that firmly preserve human oversight and ensure patient safety. I look forward to learning from colleagues across the transplant community and discussing how we can translate these advances into safer, more effective care.
A sincere thank you to the Society of Transplantation Singapore (SOT) and Dr. Matthew D'Costa for the invitation and the opportunity to contribute to this important conversation! 🙏🏻 
📅 Date: Saturday, October 3, 2026
📍 Location: National Heart Centre Singapore 
Wisit Cheungpasitporn, MD, FACP, FASN, FAST @MayoClinicNeph
Professor of Medicine, Division of Nephrology and Hypertension
AI Course Director, Mayo Clinic Alix School of Medicine
Mayo Clinic, Minnesota 
#Transplantation #ArtificialIntelligence #AIinHealthcare #KidneyTransplant #DigitalHealth #PrecisionMedicine #TransplantMedicine #MachineLearning #Nephrology #SOTASM2026 #MayoClinic

[Leticia Rolon @LeticiaRolonMD]

The inaugural @MayoClinicNeph Glomerular Diseases & Kidney Pathology course is off to an exciting start! With over 1500 patients in our GN program and >500 new glomerular consults per year, as well as >9000 kidney biopsies read by our kidney pathology colleagues per year…

[Leticia Rolon @LeticiaRolonMD]

Dr. @fervenzaf reminding us why we need to keep an eye on the source of inflammation in LN! Focusing on proteinuria may be misleading. Redefining “Endpoints in Lupus Nephritis” #Dontbiopsylava Better yet, monitor the immunologic activity to guide your management @MayoClinicNeph

[Fernando Fervenza @fervenzaf]

First GN course going on now! 😀

[Sandra Herrmann MD, FASN @HerrmannMd]

@MCFNephFellows @ShaneBobart Only the best! 👏❤️

[Sandra Herrmann MD, FASN @HerrmannMd]

Happening now ! AI in healthcare by @wisit661 !Nephrology Grand Rounds @MayoClinicNeph

[Swetha Kanduri @SwethaKanduriMD]

Absolute pleasure to be a part of the @onconephsociety PositionStatement committee and so very grateful to work alongside with team on “Anemia Management in patients with CKD and Cancer” @UTHealthSANeph @HerrmannMd @onconeph

[Mayo Clinic Nephrology @MayoClinicNeph]

“Contrast-Associated Acute Kidney Injury: Comprehensive Review of Risk Factors, Pathophysiology, Definition and Management”
@josearriolam @wisit661 @mandeep_mayo @MayoProceedings
https://t.co/eLyKT0BX16

[Mayo Clinic Nephrology @MayoClinicNeph]

Drug-Induced Thrombotic Microangiopathy in Cancer

@Mbarbarini @HerrmannMd @asnpublications

https://t.co/va78pMs66l

[Sandra Herrmann MD, FASN @HerrmannMd]

Drug-Induced Thrombotic Microangiopathy in Cancer
Can Kidney Biopsy Help Unravel This Highly Heterogeneous Pathologic Entity? 👇🏽Check out this editorial @MBarbarini
#onconephrology

[Mayo Clinic Nephrology @MayoClinicNeph]

Drug-Induced Thrombotic Microangiopathy in Cancer

@Mbarbarini @HerrmannMd @asnpublications

https://t.co/va78pMs66l